Related Experiment Videos
Treatment of Lyme disease
Abstract:
We compared phenoxymethyl penicillin, erythromycin, and tetracycline, in each instance 250 mg four times a day for 10 days, for the treatment of early Lyme disease (stage 1). None of 39 patients given tetracycline developed major late complications compared with 3 of 40 penicillin-treated patients and 4 of 29 given erythromycin (p = 0.07). However, with all three antibiotic agents, nearly half of patients had minor late symptoms. For neurologic abnormalities (stage 2), 12 patients were treated with high-dose intravenous penicillin, 20 million U a day for 10 days. Pain usually subsided during therapy, but a mean of 7 to 8 weeks was required for complete recovery of motor deficits. For the treatment of established arthritis (stage 3), 20 patients were assigned treatment with intramuscular benzathine penicillin (7.2 million U) and 20 patients received saline. Seven of the 20 penicillin-treated patients (35%) were apparently cured, but all 20 patients given placebo continued to have attacks of arthritis (P less than 0.02). Of 20 arthritis patients treated with intravenous penicillin G, 20 million U a day for 10 days, 11 (55%) were apparently cured. Thus, all 3 stages of Lyme disease can be treated with antibiotic therapy, but some patients with late disease may not respond.
Insights
Tetracycline showed promise in early Lyme disease treatment, with fewer complications than penicillin or erythromycin. Antibiotic therapy can treat all Lyme disease stages, though late-stage patients may not fully recover.
Area of Science:
- Infectious Diseases
- Bacteriology
- Clinical Medicine
Background:
- Lyme disease is a tick-borne illness caused by Borrelia burgdorferi.
- The disease progresses through stages, affecting the skin, nervous system, joints, and heart.
- Effective antibiotic treatment is crucial for managing Lyme disease and preventing long-term complications.
Purpose of the Study:
- To evaluate the efficacy of different antibiotics in treating early Lyme disease (Stage 1).
- To assess the effectiveness of antibiotic therapy for neurologic abnormalities (Stage 2) and established arthritis (Stage 3) of Lyme disease.
Main Methods:
- Stage 1: Patients received phenoxymethyl penicillin, erythromycin, or tetracycline (250 mg four times daily for 10 days).
- Stage 2: Patients with neurologic abnormalities received high-dose intravenous penicillin (20 million U/day for 10 days).
- Stage 3: Patients with arthritis received intramuscular benzathine penicillin, intravenous penicillin G, or placebo.
Main Results:
- Tetracycline-treated patients had no major late complications, compared to penicillin and erythromycin groups (p=0.07).
- Nearly half of patients experienced minor late symptoms regardless of antibiotic used in Stage 1.
- Intravenous penicillin G showed higher cure rates (55%) for established arthritis than intramuscular penicillin (35%) or placebo.
Conclusions:
- Antibiotic therapy is effective for all stages of Lyme disease.
- Tetracycline may be a preferred option for early Lyme disease due to fewer complications.
- Some patients with late-stage Lyme disease may not achieve a complete cure with current antibiotic regimens.